Financial Performance - Net profit attributable to shareholders decreased by 154.50% to a loss of CNY 32,307,506.76 compared to the same period last year[7] - Operating revenue decreased by 53.44% to CNY 166,154,435.96 compared to the previous year[7] - Basic earnings per share decreased by 154.63% to a loss of CNY 0.118 compared to the previous year[7] - The company reported a net loss of CNY -113,613,239.94 compared to CNY -88,539,729.44 at the beginning of the year, indicating a worsening of approximately 28.3%[24] - Total operating revenue for Q1 2015 was ¥166,154,435.96, a decrease of 53.4% compared to ¥356,823,514.80 in the same period last year[31] - The net profit for Q1 2015 was a loss of ¥32,299,735.42, compared to a profit of ¥58,226,644.23 in Q1 2014, representing a significant decline[31] - The company reported a total profit loss of ¥33,227,708.25 for Q1 2015, compared to a profit of ¥65,360,195.00 in the previous year[31] Cash Flow - Net cash flow from operating activities increased by 682.91% to CNY 152,781,832.94 compared to the same period last year[7] - Cash flow from operating activities for Q1 2015 was ¥152,781,832.94, a substantial increase from ¥19,514,643.33 in Q1 2014[39] - Operating cash flow for Q1 2015 was CNY 137,716,240.88, a significant improvement compared to a net outflow of CNY 15,407,623.61 in the same period last year[42] - Total cash inflow from financing activities was CNY 178,000,000.00, up from CNY 65,000,000.00 in the previous year[42] - Net cash flow from financing activities was CNY 66,094,143.76, compared to a net outflow of CNY 17,115,325.87 in the prior year[43] - Total cash outflow from operating activities was CNY 183,095,163.67, down from CNY 219,629,158.09 in the previous year[42] - The net increase in cash and cash equivalents was CNY -28,013,225.79, compared to a decrease of CNY -18,825,348.27 in the same period last year[43] Assets and Liabilities - Total assets increased by 4.13% to CNY 2,499,847,646.72 compared to the end of the previous year[7] - Current assets rose to CNY 1,240,532,734.01, up from CNY 1,127,230,025.26, indicating an increase of about 10%[22] - Total liabilities increased to CNY 1,600,713,054.26 from CNY 1,476,468,804.51, indicating a growth of about 8.4%[24] - Owner's equity decreased to CNY 899,134,592.46 from CNY 924,325,894.03, a decline of approximately 2.7%[24] - Long-term borrowings decreased by 100% to CNY 30,000,000.00, indicating a complete repayment[16] Operational Metrics - The company experienced a decrease in sales volume and prices, leading to reduced operating income and costs[14] - The company’s operating costs decreased by 53.05% to CNY 153,598,553.24 from CNY 327,141,416.40 in the previous year[16] - The company’s sales expenses decreased by 33.69% to CNY 13,423,187.61 from CNY 20,243,894.67 in the same period last year[16] - The company incurred financial expenses of ¥19,450,573.18 in Q1 2015, up from ¥15,865,294.67 in the same period last year[31] Shareholder Information - The number of shareholders increased to 16,453 at the end of the reporting period[10] - The company is facing uncertainty regarding the payment of the auction price and commission for the judicial auction of its largest shareholder's equity, which may lead to a change in the major shareholder[17] - The company has committed to avoiding competition with its major shareholder and related parties to reduce and regulate related transactions[18] Other Financial Activities - The company received government subsidies amounting to CNY 1,535,674.36, contributing to increased non-operating income[8] - The company reported a significant increase in prepayments due to increased advance payments by its subsidiary[13] - Prepayments increased by 258.29% to CNY 112,531,418.90 from CNY 31,407,673.22 at the beginning of the year[16] - The company’s other receivables increased by 58.13% to CNY 91,981,770.19 from CNY 58,168,316.99 at the beginning of the year[16] - The company reported a net cash outflow from investing activities of CNY -234,005,187.10, a significant decline compared to CNY 10,612,616.77 in the previous year, representing a decrease of 2,304.97%[16]
宁科生物(600165) - 2015 Q1 - 季度财报